By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novartis Pharma AG 

Lichtstrasse 35

Basel    CH-4002  Switzerland
Phone: 41-61-324-111 Fax: 41-61-324-8001




Beyond Genomics, Inc. 

Emisphere Technologies, Inc.  Salmon calcitonin

Company News
Elbit Imaging Ltd. (EMITF) Announces Its Indirect Associate, Gamida Cell, Has Entered Into Agreement With Novartis Pharma AG (NVS) 10/12/2015 10:12:56 AM
Novartis Pharma AG (NVS) Unloads Certain Specialty Product Rights to Merus for $29.5 Million 5/22/2015 5:19:32 AM
Ophthotech Corporation (OPHT) Achieves Second $50 Million Enrollment Milestone Under Ex-US Licensing And Commercial Agreement With Novartis Pharma AG (NVS) For Fovista 3/10/2015 11:37:17 AM
Proteus Digital Health, Inc. Grows Leadership Team And Board Of Directors With Former Executives From Novartis Pharma AG (NVS), Novartis Pharma AG (NVS) And Egreetings Network 4/16/2014 9:33:11 AM
Unigene Laboratories, Inc. (UGNE) Announces Novartis Pharma AG (NVS)' Disclosure of First Interpretable Results from Phase 3 Trial of Calcitonin (SMC021) in the Treatment of Post-menopausal Osteoporosis 11/14/2011 7:08:13 AM
Novartis Pharma AG (NVS) Selects Veeva Systems, Inc. CRM for Global Deployments 10/19/2010 10:41:35 AM
Emisphere Technologies, Inc. (EMIS), Novartis Pharma AG (NVS). Nordic Bioscience A/S Provide Update on Osteoarthritis Phase III Study With Oral Calcitonin; Drug Deemed Safe But Not Effective, Emisphere Stock Falls 61.15% at 1:37PM EDT 7/23/2010 7:08:08 AM
Emisphere Technologies, Inc. (EMIS) Announces Expanded Collaboration Agreement With Novartis Pharma AG (NVS) and Cancellation of Convertible Promissory Note 6/4/2010 9:58:37 AM
Titan Pharmaceuticals (TTP) Provides Estimate of Upcoming Royalty Payment 4/22/2010 10:51:38 AM
Emisphere Technologies, Inc. (EMIS) Partner Initiates Second Phase I Trial for Oral PTH Therapy for the Treatment of Postmenopausal Osteoporosis 4/15/2010 9:55:23 AM